Req. No. 6820 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 58th Legislature (2021)
HOUSE BILL 2810 By: Sneed
AS INTRODUCED
An Act relating to public health; creating the Kidney
Disease Prevention and Education Task Force Act;
stating legislative findings; creat ing the Kidney
Disease Prevention and Education Task Force;
providing for membership; providing for meeting
dates; providing that members serve without
compensation; providing for staffing; requiring
certain study, plan, and reports; providing a sunset
date; providing for codification; and providing an
effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 7315 of Titl e 63, unless there
is created a duplication in numbering, reads as follows:
This act shall be known and may be cited as the "Kidney Disease
Prevention and Education Task Force Act ".
SECTION 2. NEW LAW A new section of law to be codi fied
in the Oklahoma Statutes as Section 7316 of Title 63, unless there
is created a duplication in numbering, reads as follows:
The Legislature finds that:
Req. No. 6820 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
A. Kidney disease is the ninth-leading cause of death in the
United States. An estimated thirty -seven million (37,000,000)
people in the United States have chronic kidney disease and more
than seventy-two thousand (72,000) people in the State of Oklahoma
are living with the disease. Early chronic kidney disease has no
signs or symptoms and without ea rly detection can progress to kidney
failure.
B. If a person has high blood pressure, heart disease,
diabetes, or a family history of kidney failure, the risk of kidney
disease is greater. In Oklahoma, fourteen percent (14%) of all
adults have diabetes, and nearly forty percent (40%) have high blood
pressure. The prevalence of diabetes, heart disease, and
hypertension is higher for African Americans, who develop kidney
failure at a rate of nearly four to one compared to Caucasians,
while Hispanics have a thirty percent (30%) higher risk of
developing kidney failure. Almost twenty-nine percent (29%) of the
people waiting for a kidney in the United States identify as African
American, but, in 2019, less than twenty-six percent (26%) of those
waiting received a kidney.
C. Although dialysis is a life -extending treatment, the best
and most cost-effective treatment for kidney failure is a kidney
transplant. Currently, the wait in Oklahoma for a deceased donor
kidney is five (5) to seven (7) years, and nationally twelve people
die while waiting every day.
Req. No. 6820 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
D. If chronic kidney diseas e is detected early and managed
appropriately, the individual can receive treatment sooner to help
protect the kidneys, the deterioration in kidney function can be
slowed or even stopped, and the risk of associated cardiovascular
complications and other complications can be reduced.
E. In light of the Covid -19 pandemic and the increased risk of
infection to patients with preexisting conditions and Covid-19
patients acquiring acute k idney disease, it is imperative to provide
support for those with kidney disease.
SECTION 3. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 7317 of Title 63, unless there
is created a duplication in numbering, reads as follows:
A. There is hereby created the Kidney Disease Prevention and
Education Task Force.
B. The Task Force shall consist of at least fourteen (14)
members to be appointed or selected as follows:
1. The President Pro Tempore of the Oklahoma State Senate, or
his or her designee, who shall serve as co chair;
2. The Speaker of the Oklahoma House of Representatives, or his
or her designee, who shall serve as co chair;
3. One member of the Oklahoma State Senate, who shall be
appointed by the minority leader of the Senate;
4. One member of the Oklahoma House of Representatives, who
shall be appointed by the minority leader of the House;
Req. No. 6820 Page 4 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
5. Two members, appointed by the G overnor, one of whom shall
represent the State Department of Health and the other of whom shall
represent a nationwide, nonprofit organization dedicated to kidney
research, education, and support ;
6. The Secretary of State, or his or her designee;
7. Seven members appointed by the co chairs, as follows:
a. one member representing the renal care provider
community,
b. one member representing a medical ce nter with a
kidney-related program,
c. one member representing the kidney physician
community,
d. one member representing a nonprofit organ procurement
organization,
e. one member representing the kidney patient community
in Oklahoma,
f. one member representing tribal governments, and
g. one member representing providers of emergency
ambulance transportation ; and
8. Other additional members, appointed by the cochairs as they
see fit, representing public health clinics, community health
centers, minority health organizations, and private health insurers.
C. The Task Force shall conduct an organizational meeting not
later than December 31, 2021. A majority of the members pres ent at
Req. No. 6820 Page 5 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
the organizational meeting or any subsequent meeting shall
constitute a quorum for the purpose of any action taken including
the preparation and approval of the report s required by subsection G
of this section. The Task Force shall be authorized to meet as
necessary in order to perform the duties imposed upon it.
D. Members of the Task Force shall serve without compensation .
E. Staff assistance for the Task Force shall be provided by the
staff of the State Department of Health.
F. The Task Force shall conduct a study regarding chronic
kidney disease, transplantations, living and deceased kidney
donation, and the disparities in affliction rates among racial
groups. After the study is complete, the Task Force shall develop a
sustainable plan to rai se awareness about early detection, promote
health equity, promote transplantation, and reduce the burden of
kidney disease throughout Oklahoma. The plan shall include an
ongoing campaign that includes health education workshops and
seminars, preventive screenings, relevant research, and that
promotes social media campaigns and television and radio
commercials.
G. The Task Force shall submit an initial report to the
Governor, the Speaker of the Oklahoma House of Representatives, and
the President Pro Temp ore of the Oklahoma State Senate not later
than December 31, 2022 , and annually thereafter .
Req. No. 6820 Page 6 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
H. The provisions of this section shall cease to have the force
and effect of law and the Task Force shall terminate effective
January 1, 2027.
SECTION 4. This act shall become effective November 1, 2021.
58-1-6820 AB 01/10/21